Medical Marijuana use is widely accepted in different parts of the work and It’s long known by the scientists that compound derived from marijuana have some cancer fighting abilities. A recent discovery demonstrates how exactly one compound may fight tumours. It is determined that marijuana’s chief active ingredient, THC, may prevent cancer cell growth by a team at the University of East Anglia (UEA).
Mice cancer is given in the form of human cancer cells by the research team at the Complutense University of Madrid, Spain. The mice was injected with THC, by the students, and found according to UEA’s official release, two cell receptors responded to THC and contributed to the chemical’s anti-cancer factors.
When THC was applied to tumours induced in mice using human breast cancer cells, the action between two cannabinoid cell receptors CB2 and GRP55 were responsible for THC’s anti-tumour benefits.
The endocannabinoid system is known as a communications network in the brain and the body that is indulged in a number of physiological processes that affect a person’s feelings, motor skills and memory. The body’s naturally-occuring endocannabinoids as well as the cannabinoids found in marijuana, like THC is onto the EC system. And it is also found by the scientists that the CB2 receptor specifically is sensitive to the therapeutic properties of marijuana-based compounds.
It is stated that THC, the major active component of marijuana, has anti-cancer properties and that this compound is known to act through a specific family of cell receptors called cannabinoid receptors, by Dr. Peter McCormick, of UEA’s pharmacy school. Also stating that the team is not sure uptil now that which receptor in particular is responsible for the cancer-inhibiting effects.
According to Dr. McCormick these effects are mediated by the joint action of the cannabinoid receptor kind. He ensures that their “findings help explain some of the well-known but still poorly understood effects of THC at low and high doses on tumour (sic) growth,” but compels that cancer patients should not self-medicate until scientists and doctors know more about the exact concentration of THC necessary and understand the mechanisms of the cannabinoid receptor better.
It is hoped by him that the research will lead to a secure, celluloid cancer-treating compound in the future. Medical Marijuana is keen enough to welcome such researches and further studies to strengthen the point that Marijuana is useful are conducting in different parts of the world.